HE4 AND CA125 IN BENIGNANDMALIGNANTDISEASES

被引：0
|
作者：
Kirschenhofer, A. [2 ]
Lenhard, M. [2 ]
Hertlein, L. [2 ]
Fuerst, S. [2 ]
Mayr, D. [3 ]
Nagel, D. [2 ]
Hofmann, K. [2 ]
Krocker, K. [2 ]
Burges, A. [1 ]
Lorenz, S. [4 ]
Stieber, P. [2 ]
机构：
[1] Univ Munich, Dept Clin Chem, Munich, Germany
[2] Univ Munich, Dept Obstet & Gynecol, Munich, Germany
[3] Univ Munich, Dept Pathol, Munich, Germany
[4] Abbott GmbH & Co KG, Wiesbaden, Germany
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2011年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S253 / S253
页数：1
相关论文
共 50 条
  • [1] HE4 and CA125 in ovarian malignancy
    Perovic, M.
    CLINICA CHIMICA ACTA, 2022, 530 : S62 - S62
  • [2] HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Kotowicz, B.
    Fuksiewicz, M.
    Kowalska, M.
    Sobiczewski, P.
    Skrzypczak, M.
    Spiewankiewicz, B.
    Kaminska, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [3] Preoperative CA125 and HE4 in patients with endometrial cancer
    Antonsen, Sofie
    Hogdall, Estrid
    Andersen, Erik
    Jochumsen, Kirsten
    Lydolph, Magnus
    Hogdall, Claus
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2012, 91 : 63 - 63
  • [4] CA125 and HE4: Measurement Tools for Ovarian Cancer
    Zhao, Tingting
    Hu, Weiping
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2016, 81 (05) : 430 - 435
  • [5] Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer
    Granato, Teresa
    Midulla, Cecilia
    Longo, Flavia
    Colaprisca, Barbara
    Frati, Luigi
    Anastasi, Emanuela
    TUMOR BIOLOGY, 2012, 33 (05) : 1335 - 1339
  • [6] HE4和HE4/CA125并联诊断卵巢癌的系统评价
    危敏
    莫小阳
    吴江
    孙朝晖
    激光生物学报, 2016, 25 (05) : 443 - 450
  • [7] DISEASE RELAPSE IN OVARIAN CANCER PATIENTS DETECTED BY HE4 AND CA125
    Steffensen, K.
    Waldstrom, M.
    Brandslund, I.
    Lund, B.
    Sorensen, S. M.
    Petzold, M.
    Jakobsen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 187 - 188
  • [8] Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4
    Ghose, Aruni
    McCann, Lucy
    Makker, Shania
    Mukherjee, Uma
    Gullapalli, Sri Vidya Niharika
    Erekkath, Jayaraj
    Shih, Stephanie
    Mahajan, Ishika
    Sanchez, Elisabet
    Uccello, Mario
    Moschetta, Michele
    Adeleke, Sola
    Boussios, Stergios
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [9] Comparison of HE4 and CA125 levels in women with benign gynecologic disorders
    Delic, Ratko
    Stefanovic, Mario
    Krivec, Stefka
    Weber, Vladimir
    Koren, Jakob
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : 543 - 547
  • [10] Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
    Andersen, M. Robyn
    Goff, Barbara A.
    Lowe, Kimberly A.
    Scholler, Nathalie
    Bergan, Lindsay
    Drescher, Charles W.
    Paley, Pamela
    Urban, Nicole
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 378 - 383
12345